Local Institution - 0243 — Waukee, Iowa

Local Institution - 0243 is a clinical research site located in Waukee, Iowa, United States 50309.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Local Institution - 0243 has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Follicular Lymphoma.

Sponsors: Celgene.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Waukee

Browse all research sites in Iowa · View every site in Waukee

• University of Iowa Health Care
• University of Iowa - Waukee ( Site 0111)
• University of Iowa
• University of Iowa Health Care, Mission Cancer + Blood
• UI Health Care Mission Cancer and Blood - Waukee Clinic
• Mission Cancer Blood
• GSK Investigational Site
• Mission Cancer and Blood
• Research Site
• Local Institution - 0461
• Mission Blood & Cancer Care ( Site 0114)
• Mission Blood and Cancer - MercyOne Cancer Center

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Local Institution - 0243?

Local Institution - 0243 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Local Institution - 0243 conducted?

Local Institution - 0243 has 1 clinical trials on record, with 1 currently active. Their work covers Follicular Lymphoma.

Is Local Institution - 0243 accredited by Crixeo Clinical Trials?

Local Institution - 0243 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Local Institution - 0243?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.